Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer's Disease

被引:11
|
作者
Bertrand, Elodie [1 ]
van Duinkerken, Eelco [1 ,2 ,3 ]
Landeira-Fernandez, J. [1 ]
Dourado, Marcia C. N. [4 ]
Santos, Raquel L. [4 ]
Laks, Jerson [4 ,5 ]
Mograbi, Daniel C. [1 ,6 ]
机构
[1] Pontificia Univ Catolic Rio PUC Rio, Dept Psychol, Rio De Janeiro, Brazil
[2] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Diabet Ctr, Dept Internal Med, Amsterdam, Netherlands
[4] Fed Univ Rio de Janeiro UFRJ, Ctr Alzheimers Dis, Inst Psychiat, Rio De Janeiro, Brazil
[5] Univ Grande Rio Unigranrio, Post Grad Program Translat Biomed, Caxias, Brazil
[6] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
来源
关键词
BPSD; clinical capacity; decision making; consent to treatment; dementia; Alzheimer's disease; DECISION-MAKING CAPACITY; MILD COGNITIVE IMPAIRMENT; MACARTHUR TREATMENT COMPETENCE; NEUROPSYCHIATRIC-INVENTORY; EXECUTIVE FUNCTION; MENTAL-CAPACITY; CONSENT; DEMENTIA; ANOSOGNOSIA; VERSION;
D O I
10.3389/fnagi.2017.00182
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatric disorders, such as schizophrenia and bipolar disorder. In this context, the current study explored the relationship between behavioral and psychological symptoms of dementia (BPSD) and clinical competence, especially the capacity to consent to treatment, in Alzheimer's disease (AD). Seventy-one patients with mild to moderate AD participated, completing assessments for capacity to consent to treatment, general cognition and neuropsychiatric disturbances. For each neuropsychiatric symptom, patients with and without the particular disturbance were compared on the different subscales of the MacArthur Competence Tool for Treatment (MacCAT-T; Understanding, Appreciation, Reasoning and Expression). The results showed that patients presenting delusions, as well as apathetic patients, had a lower ability to express a clear treatment choice compared to patients without these symptoms. By contrast, patients with dysphoria/ depression had higher scores on this variable. Additionally, AD patients with euphoria had more difficulties discussing consequences of treatment alternatives compared to patients without this disturbance. None of the differences were confounded by global cognition. There were no between-group differences in clinical decision-making for patients with hallucinations, agitation/aggression, anxiety, irritability, disinhibition and aberrant motor behavior. These findings highlight the importance of taking BPSD into account when assessing decision-making capacity, especially clinical competence, in AD. Furthermore, reducing BPSD may lead to better clinical competence in patients with AD, as well as to improvements in patients and caregivers' quality of life.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease
    Boublay, Nawele
    Bouet, Romain
    Dorey, Jean-Michel
    Padovan, Catherine
    Makaroff, Zaza
    Federico, Denis
    Gallice, Isabelle
    Barrellon, Marie-Odile
    Robert, Philippe
    Moreaud, Olivier
    Rouch, Isabelle
    Krolak-Salmon, Pierre
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (04) : 1343 - 1353
  • [22] The impact of behavioral and psychological symptoms related to Alzheimer disease in primary care.
    Boustani, MA
    Callahan, C
    Perkins, T
    Unverzagt, F
    Austrom, M
    Hui, S
    Damush, T
    Fultz, B
    Hendrie, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S148 - S149
  • [23] The Impact of Angiotensin-Converting Enzyme Gene on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease
    Hsieh, Sun-Wung
    Liu, Ming-Wei
    Huang, Ling-Chun
    Wu, Meng-Ni
    Yang, Yuan-Han
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (14) : 1269 - 1275
  • [24] In Alzheimer's disease, the clinical expression of behavioral and psychological signs and symptoms is early and specific of neuropathological stages
    Michel, B. F.
    Luciani, V.
    Geda, Y. E.
    Sambuchi, N.
    Paban, V.
    Azorin, J. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2010, 36 (04): : 314 - 325
  • [25] Behavioral and psychological symptoms in Alzheimer's disease: Frequency and relationship with duration and severity of the disease
    Piccininni, M
    Di Carlo, A
    Baldereschi, M
    Zaccara, G
    Inzitari, D
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (5-6) : 276 - 281
  • [26] Effects of donepezil on behavioral and psychological symptoms in Korean patients with Alzheimer's disease
    Yoon, JS
    Kim, JM
    Shin, IS
    Kim, SW
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S328 - S328
  • [27] Future Therapeutic Strategies for Alzheimer's Disease: Focus on Behavioral and Psychological Symptoms
    Kwon, Kyoung Ja
    Kim, Hahn Young
    Han, Seol-Heui
    Shin, Chan Young
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [28] Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer's disease
    Kim, Hyun
    Lee, Kang Joon
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1887 - 1896
  • [29] Use of Antipsychotics for Psychological and Behavioral Symptoms of Dementia in Elderly with Alzheimer's Disease
    Forgerini, M.
    Fernandes Garduroz, J. C.
    Herdeiro, M. T.
    de Carvalho Mastroianni, P.
    DRUG SAFETY, 2019, 42 (10) : 1268 - 1268
  • [30] The effects of donepezil on behavioral and psychological symptoms of dementia in patients with Alzheimer's disease
    Holmes, C
    Dean, C
    Clare, C
    Vethanayagam, S
    Olivieri, S
    Langley, A
    Gunawardena, R
    Hogg, S
    Damms, J
    Wilkinson, D
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 83 - 84